Optimized Novel Wireless Assessment of Respiratory and Circulatory Dirstress - Alarm Validation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEske Kvanner Aasvang
About this trial
The ONWARD study evaluates user experiences from continuous vital sign monitoring alarms sent to the clinical staff in case of deviating vital signs at the general hospital ward. User experiences are evaluated though a 5-point likert questionnaire.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration.
Expected admission for more than 24 hours to a general ward.
Disqualifiers
Having implanted electronic devices (such as pacemaker or Implantable Cardioverter Defibrillator (ICD) device).
Known pregnancy or breastfeeding
Inability to give informed consent.
The participant expected not to cooperate with study procedures.
Trial design
Treatments tested in this trial
- Continuous vital sign monitoring
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Eske Kvanner Aasvang
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution
Rigshospitalet, Denmark
Collaborator
University Hospital Bispebjerg and Frederiksberg
Collaborator
Source ClinicalTrials.gov